- Home
- GP vs INM Comparison
GP vs INM Comparison
Compare GP & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GP | INM |
|---|---|---|
| Founded | 2010 | 1981 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 7.7M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GP | INM |
|---|---|---|
| Price | $1.35 | $1.43 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 239.9K | 97.4K |
| Earning Date | 02-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,942,633.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.50 |
| 52 Week Low | $0.23 | $0.58 |
| 52 Week High | $4.00 | $2.50 |
Technical Indicators
Market Signals| Indicator | GP | INM |
|---|---|---|
| Relative Strength Index (RSI) | 52.80 | N/A |
| Support Level | $1.48 | N/A |
| Resistance Level | $1.80 | N/A |
| Average True Range (ATR) | 0.11 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 35.04 | 0.00 |
Price Performance
Historical ComparisonAbout GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.